Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Tamara Wexler"'
Autor:
Timothy R. Elliott, Yu-Yu Hsiao, Kathleen Randolph, Randall J. Urban, Melinda Sheffield-Moore, Richard B. Pyles, Brent E. Masel, Tamara Wexler, Traver J. Wright
Publikováno v:
PLoS ONE, Vol 18, Iss 12 (2023)
Externí odkaz:
https://doaj.org/article/5b8534aaf8584326af5fc35c3259a5af
Autor:
Tamara Wexler, Gabrielle Page-Wilson
Dopamine agonists are a key tool in the therapeutic arsenal of endocrinologists worldwide. They exert their effects by binding to dopamine 2 (D2) receptors expressed by pituitary tumor cells, to modulate hormonal secretion and tumor size. They are th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::28559e8952552236f4d62de4e437e452
https://doi.org/10.22541/au.166746244.47678512/v1
https://doi.org/10.22541/au.166746244.47678512/v1
Autor:
Tamara Wexler
Publikováno v:
Endocrine Abstracts.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1d41d0657f94186ce2b10a4cfd78e696
https://doi.org/10.1530/endoabs.81.ep794
https://doi.org/10.1530/endoabs.81.ep794
Autor:
Eliza P. Teo, Jonathan G. Teoh, Pouneh K. Fazeli, Michael H. Picard, Ronen Durst, Brian M. Russell, Rory B. Weiner, Eleanor L. Lam, Anne Klibanski, David McCarty, Anu V. Gerweck, Tamara Wexler, Karen K. Miller
Publikováno v:
Growth Hormone & IGF Research. 26:17-23
Objective Although growth hormone (GH) replacement is prescribed for patients with hypopituitarism due to many etiologies, it is not routinely prescribed for patients with GH deficiency (GHD) after cure of acromegaly (acroGHD). This study was designe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5a7386dad5bdbc862e5c709bcf10fb10
https://doi.org/10.1016/j.ghir.2015.12.003
https://doi.org/10.1016/j.ghir.2015.12.003
Autor:
Michael H. Picard, Anne Klibanski, Lindsay Gunnell, Tamara Wexler, Zehra B. Omer, Pouneh K. Fazeli, Ronen Durst, Karen K. Miller, David McCarty
Publikováno v:
Growth Hormone & IGF Research. 20:333-337
Growth hormone excess and growth hormone deficiency (GHD) are both associated with increased cardiovascular morbidity. A specific acromegaly-related cardiomyopathy has been described, characterized in part by increased left ventricular mass (LVM). Gr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d57f475c476110a0989e447a4ab951f2
https://doi.org/10.1016/j.ghir.2010.05.003
https://doi.org/10.1016/j.ghir.2010.05.003
Autor:
Brooke Swearingen, Andrea L. Utz, Lisa B. Nachtigall, Tamara Wexler, Karen Kuhlthau, Catherine Beauregard, Karen K. Miller, Gwenda J. Graham, Zehra B. Omer, Beverly M. K. Biller, Anne Klibanski, Lindsay Gunnell, Jay S. Loeffler
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 94:2471-2477
Context: Both GH deficiency (GHD) and GH excess are associated with a decreased quality of life. However, it is unknown whether patients with GHD after treatment for acromegaly have a poorer quality of life than those with normal GH levels after cure
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dcd0a91f70d664075e084a61b8882ca0
https://doi.org/10.1210/jc.2008-2671
https://doi.org/10.1210/jc.2008-2671
Autor:
Karen K. Miller, Anna B. Binstock, David B. Herzog, Erinne Meenaghan, Anne Klibanski, Alicia M. Zha, Elizabeth A. Lawson, Tamara Wexler, Madhusmita Misra
Publikováno v:
The Journal of Clinical Psychiatry. 68:959-965
Objective Anorexia nervosa is associated with a high prevalence of psychiatric comorbidities, including anxiety and depression, and with endocrine dysfunction, including relative androgen deficiency compared with healthy young women. Because androgen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fdd2485f50c959feb0771ff6be872068
https://doi.org/10.4088/jcp.v68n0621
https://doi.org/10.4088/jcp.v68n0621
Autor:
Linda C. Hemphill, Tamara Wexler, Karen K. Miller, Beverly M. K. Biller, Brooke Swearingen, Nicholas A. Tritos, Anne Klibanski, Eleanor Lin, Jay S. Loeffler, Lisa B. Nachtigall
Publikováno v:
Clinical endocrinology. 77(3)
Both growth hormone (GH) excess and GH deficiency are associated with abnormalities in body composition and biomarkers of cardiovascular risk in patients with pituitary disorders. However, the effects of developing GH deficiency after definitive trea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fc5ef43ac125e99652cd514d2ecde9fa
https://pubmed.ncbi.nlm.nih.gov/22315983
https://pubmed.ncbi.nlm.nih.gov/22315983
Autor:
Tamara Wexler, Karen K. Miller, Pouneh K. Fazeli, Lindsay Gunnell, Beverly M. K. Biller, Gwenda J. Graham, Brooke Swearingen, Linda C. Hemphill, Anne Klibanski, Catherine Beauregard, Lisa B. Nachtigall, Jay S. Loeffler
The effects of GH replacement therapy in patients who develop GH deficiency (GHD) after cure of acromegaly have not been established in a placebo-controlled study.The objective of the study was to determine whether GH replacement improves body compos
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1df915934466b0f44ee9fc82c92d4264
https://europepmc.org/articles/PMC2840863/
https://europepmc.org/articles/PMC2840863/